Net Income (Quarterly) Chart

View Net Income (Quarterly) for SEER.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (Quarterly) Chart
Start Trial

Historical Net Income (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -16.90M
March 31, 2026 -16.84M
December 31, 2025 -15.99M
September 30, 2025 -18.23M
June 30, 2025 -19.42M
March 31, 2025 -19.95M
December 31, 2024 -21.74M
September 30, 2024 -21.33M
June 30, 2024 -22.85M
March 31, 2024 -20.68M
December 31, 2023 -17.80M
September 30, 2023 -21.09M
June 30, 2023 -23.43M
March 31, 2023 -23.96M
Date Value
December 31, 2022 -22.53M
September 30, 2022 -23.98M
June 30, 2022 -22.82M
March 31, 2022 -23.65M
December 31, 2021 -19.74M
September 30, 2021 -18.38M
June 30, 2021 -16.62M
March 31, 2021 -16.43M
December 31, 2020 -12.94M
September 30, 2020 -8.229M
June 30, 2020 -6.117M
March 31, 2020 -5.493M
December 31, 2019 -5.146M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
Champions Oncology, Inc. -0.667M
Medpace Holdings, Inc. 121.36M
Avantor, Inc. 38.10M
Personalis, Inc. -31.68M
Adaptive Biotechnologies Corp. -39.94M